Borderline BE study Failure [Study As­sess­ment]

posted by Samaya B – India, 2014-10-14 11:02 (3863 d 10:15 ago) – Posting: # 13696
Views: 8,343

Dear All,

For Product X (IR tablets), full replicated BE study was performed on 56 volunteers under fasting state (EU submission).

When data for first half subjects (N: 28) was analysed, we got following results.
Cmax ratio: 87 (CI: 80.88-95.13)
AUC ratio: 87 (CI: 81.85-94.18)

Analysis of full data set (N: 56)
Cmax ratio: 84.32 (CI: 79.89-89.00)
AUC ratio: 86.9 (CI: 83.02-90.96)

%ISCV Cmax: 25
%ISCV AUC: 20
Power ~100
No outlier detected.

Is there any possibility to get through by any means or study to be repeated?
Or we should go ahead with the reformulation??
PROC GLM is used for stat calculation

Kindly advice.
Thanks!

Regards,
Samaya.


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
90 visitors (0 registered, 90 guests [including 56 identified bots]).
Forum time: 21:17 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5